Tackling type 2 diabetes-associated cardiovascular and renal comorbidities: a key challenge for drug development

Ernest A. Adeghate; Huba Kalász; Saeeda Al Jaberi; Jennifer Adeghate; Kornelia Tekes

doi:10.1080/13543784.2021.1865914

Tackling type 2 diabetes-associated cardiovascular and renal comorbidities: a key challenge for drug development

Ernest A. Adeghate
, Huba Kalász
, Saeeda Al Jaberi
, Jennifer Adeghate
, Kornelia Tekes

United Arab Emirates University

Semmelweis University
University of Pittsburgh

Research output: Contribution to journal › Editorial

15 Scopus citations

Original language	English
Pages (from-to)	85-93
Number of pages	9
Journal	Expert Opinion on Investigational Drugs
Volume	30
Issue number	2
DOIs	https://doi.org/10.1080/13543784.2021.1865914
State	Published - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

T2DM comorbidities
Type 2 Diabetes mellitus
cardiovascular diseases
hypoglycemic agents
renal diseases, pharmacotherapy

Access to Document

10.1080/13543784.2021.1865914

Cite this

@article{328d7934a8d545ce98a13bd81f5361fa,

title = "Tackling type 2 diabetes-associated cardiovascular and renal comorbidities: a key challenge for drug development",

keywords = "T2DM comorbidities, Type 2 Diabetes mellitus, cardiovascular diseases, hypoglycemic agents, renal diseases, pharmacotherapy",

author = "Adeghate, \{Ernest A.\} and Huba Kal{\'a}sz and \{Al Jaberi\}, Saeeda and Jennifer Adeghate and Kornelia Tekes",

year = "2021",

doi = "10.1080/13543784.2021.1865914",

language = "English",

volume = "30",

pages = "85--93",

journal = "Expert Opinion on Investigational Drugs",

issn = "1354-3784",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

TY - JOUR

T1 - Tackling type 2 diabetes-associated cardiovascular and renal comorbidities

T2 - a key challenge for drug development

AU - Adeghate, Ernest A.

AU - Kalász, Huba

AU - Al Jaberi, Saeeda

AU - Adeghate, Jennifer

AU - Tekes, Kornelia

PY - 2021

Y1 - 2021

KW - T2DM comorbidities

KW - Type 2 Diabetes mellitus

KW - cardiovascular diseases

KW - hypoglycemic agents

KW - renal diseases, pharmacotherapy

UR - https://www.scopus.com/pages/publications/85098566332

U2 - 10.1080/13543784.2021.1865914

DO - 10.1080/13543784.2021.1865914

M3 - Editorial

C2 - 33327794

AN - SCOPUS:85098566332

SN - 1354-3784

VL - 30

SP - 85

EP - 93

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

IS - 2

ER -

Tackling type 2 diabetes-associated cardiovascular and renal comorbidities: a key challenge for drug development

UN SDGs

Keywords

Access to Document

Other files and links

Cite this